COVID-19 vaccine hesitancy assessment among the educated Indian population: An online survey

International Journal of Pharmaceutical Research Pub Date : 2021-08-02 DOI:10.31838/ijpr/2021.13.03.196

K. Choudhary, P. Garapati, S. Prasad, K. Murti, S. Singh, N. Kumar

{"title":"COVID-19 vaccine hesitancy assessment among the educated Indian population: An online survey","authors":"K. Choudhary, P. Garapati, S. Prasad, K. Murti, S. Singh, N. Kumar","doi":"10.31838/ijpr/2021.13.03.196","DOIUrl":null,"url":null,"abstract":"The COVID-19 (SARS-Cov-2) pandemic has emerged in Wuhan city, China and spread globally. Despite Government lockdown process in India the number of infected people increases day by day. The only way to curb this pandemic is vaccination but still people are reluctant to receive COVID-19 vaccine. Hence online survey-based study was conducted to know Indians perception towards vaccination and reason behind their hesitancy. The online questionnaire in Google form has been circulated among people through Email and WhatsApp. 272 responses were included for analysis. The collected data were analysed by SPSS version 26 using t test and ANOVA by considering p value of less than 0.05 as significant. The study reveals that among participants 60% have good knowledge about COVID-19 and major source of information received from News (n=140), Social media (n=131) and Government website (n=101). The 58.8% among participants are willing to take vaccine and major reason behind hesitancy towards vaccine is side effect and safety concern. Focused intervention programmes and awareness campaign development will be essential by utilising social media and news channels. Govt. official needed to release newsletter through their website about safety and efficacy of vaccine to remove hesitancy among people.","PeriodicalId":14220,"journal":{"name":"International Journal of Pharmaceutical Research","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31838/ijpr/2021.13.03.196","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

The COVID-19 (SARS-Cov-2) pandemic has emerged in Wuhan city, China and spread globally. Despite Government lockdown process in India the number of infected people increases day by day. The only way to curb this pandemic is vaccination but still people are reluctant to receive COVID-19 vaccine. Hence online survey-based study was conducted to know Indians perception towards vaccination and reason behind their hesitancy. The online questionnaire in Google form has been circulated among people through Email and WhatsApp. 272 responses were included for analysis. The collected data were analysed by SPSS version 26 using t test and ANOVA by considering p value of less than 0.05 as significant. The study reveals that among participants 60% have good knowledge about COVID-19 and major source of information received from News (n=140), Social media (n=131) and Government website (n=101). The 58.8% among participants are willing to take vaccine and major reason behind hesitancy towards vaccine is side effect and safety concern. Focused intervention programmes and awareness campaign development will be essential by utilising social media and news channels. Govt. official needed to release newsletter through their website about safety and efficacy of vaccine to remove hesitancy among people.

查看原文本刊更多论文

印度受教育人群COVID-19疫苗犹豫评估:一项在线调查

新型冠状病毒肺炎(SARS-Cov-2)大流行在中国武汉市出现，并在全球蔓延。尽管印度政府采取了封锁措施，但感染人数仍在日益增加。遏制这种大流行的唯一方法是接种疫苗，但人们仍然不愿意接种COVID-19疫苗。因此，进行了基于在线调查的研究，以了解印度人对疫苗接种的看法以及他们犹豫背后的原因。谷歌形式的在线问卷已通过电子邮件和WhatsApp在人群中分发。272份回复被纳入分析。收集的资料采用SPSS 26版进行分析，采用t检验和方差分析，以p值小于0.05为显著性。研究显示，60%的参与者对COVID-19有良好的了解，主要信息来源是新闻(n=140)、社交媒体(n=131)和政府网站(n=101)。58.8%的参与者愿意接种疫苗，对疫苗的副作用和安全性的担忧是其犹豫的主要原因。利用社会媒体和新闻渠道，重点干预方案和提高认识运动的发展至关重要。政府官员需要通过他们的网站发布关于疫苗安全性和有效性的通讯，以消除人们的犹豫。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Pharmaceutical Research

自引率

0.00%

发文量